Lumos Pharma
Stock Forecast, Prediction & Price Target
Lumos Pharma Financial Estimates
Lumos Pharma Revenue Estimates
Lumos Pharma EBITDA Estimates
Lumos Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $230K N/A | $1.52M 562.17% | $2.05M 34.66% | Avg: $8.65M Low: $7.36M High: $11.07M avg. 322.17% | Avg: $28.26M Low: $24.04M High: $36.15M avg. 226.45% | Avg: $192.50M Low: $163.74M High: $246.21M avg. 580.99% | Avg: $16M Low: $13.61M High: $20.46M avg. -91.68% |
Net Income
% change YoY
| $-30.43M N/A | $-31.06M -2.07% | $-34.03M -9.56% | Avg: $-40.33M Low: $-20.85M High: $-8.47M avg. -18.52% | Avg: $-23.60M Low: $-15.47M High: $17.67M avg. 41.49% | Avg: $-8.71M Low: $-11.87M High: $-7.02M avg. 63.07% | Avg: $-5.53M Low: $-7.54M High: $-4.46M avg. 36.44% |
EBITDA
% change YoY
| $-31.34M N/A | $-32.04M -2.21% | $-36.57M -14.13% | Avg: $-8.65M Low: $-11.07M High: $-7.36M avg. 76.32% | Avg: $-28.26M Low: $-36.15M High: $-24.04M avg. -226.45% | Avg: $-192.50M Low: $-246.21M High: $-163.74M avg. -580.99% | Avg: $-16M Low: $-20.46M High: $-13.61M avg. 91.68% |
EPS
% change YoY
| -$3.65 N/A | -$3.71 -1.64% | -$4.18 -12.66% | Avg: -$1.83 Low: -$2.56 High: -$1.04 avg. 56.12% | Avg: -$0.25 Low: -$1.9 High: $2.17 avg. 86.18% | Avg: -$1.07 Low: -$1.46 High: -$0.86 avg. -322.37% | Avg: -$0.68 Low: -$0.93 High: -$0.55 avg. 36.44% |
Operating Expenses
% change YoY
| $31.57M N/A | $33.56M 6.28% | $38.66M 15.20% | Avg: $369.36M Low: $314.19M High: $472.44M avg. 855.30% | Avg: $1.20B Low: $1.02B High: $1.54B avg. 226.45% | Avg: $8.21B Low: $6.98B High: $10.50B avg. 580.99% | Avg: $682.53M Low: $580.58M High: $872.99M avg. -91.68% |
FAQ
What is Lumos Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 30.62% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -20.85M, average is -40.33M and high is -8.47M.
What is Lumos Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 259.48% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $7.36M, average is $8.65M and high is $11.07M.
What is Lumos Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -35.90% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$2.56, average is -$1.83 and high is $-1.04.
What is the best performing analyst?
In the last twelve months analysts have been covering Lumos Pharma stock. The most successful analyst is Yasmeen Rahimi.